Related Experiment Videos
Mortality and Antidepressants Among Individuals With Autism Spectrum Disorder: A Population-Based Cohort Study
Vincent Chin-Hung Chen1,2, Yu-Hsin Huang3,4, Yi-Lung Chen5,6,7
1Departments of Psychiatry and Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi Branch, Chiayi, Taiwan.
Summary
Antidepressant use in individuals with autism spectrum disorder (ASD) was not linked to overall or suicide mortality but significantly reduced accidental deaths. However, increased all-cause mortality was observed in younger individuals, necessitating careful monitoring.
Area of Science:
- Neuroscience
- Psychiatry
- Public Health
Background:
- Autism spectrum disorder (ASD) is associated with higher mortality rates and frequent psychiatric comorbidities.
- Antidepressants are commonly prescribed for ASD patients, but their long-term safety and impact on mortality are not well-established.
- Understanding the mortality risks associated with antidepressant use in ASD is crucial for clinical practice.
Purpose of the Study:
- To investigate the association between antidepressant use and all-cause, suicide, and accidental mortality in individuals with ASD.
- To examine age-specific effects of antidepressant use on mortality outcomes in the ASD population.
Main Methods:
- Emulated a target trial using data from the Taiwan National Health Insurance Research Database (2000-2016).
- Included individuals with ASD aged 6-64 years, followed for up to 5 years.
- Employed a three-step approach (cloning, censoring, inverse probability of censoring weighting) to mitigate immortal-time bias.
Main Results:
- Antidepressant use was not associated with increased all-cause or suicide mortality overall.
- A significant reduction in accidental-cause mortality was observed at 2 and 5 years post-initiation.
- Subgroup analyses indicated increased 2-year all-cause mortality in youths, but decreased 5-year accidental mortality in multiple age groups and decreased 5-year suicide mortality in adolescents/young adults.
Conclusions:
- Antidepressant use may reduce accidental mortality in individuals with ASD.
- Age-specific mortality risks associated with antidepressant use require careful consideration and monitoring, especially in younger populations.
- Further research is warranted to elucidate the complex relationship between antidepressant treatment and mortality outcomes in ASD.
Related Concept Videos
01:19Autism Spectrum Disorder
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
01:26Modeling in Therapy
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...